Tuesday, April 3, 2012

NeuroMetrix Makes a Deal With Wal-Mart

NeuroMetrix quietly announced a deal with Wal-Mart Canada.
"The purchase order covers the delivery of NC-stat DPNCheck devices and biosensors for use by health care professionals in 91 Wal-Mart Canada pharmacies for testing persons with diabetes for diabetic peripheral neuropathy (DPN)."

I liked this posting... SeekingAlpha.com::Wal-Mart Gets Into Diabetic Neuropathy Testing

Yesterday (02012.04.02), NURO opened at $0.82 after a previous close of $0.74. It hit an intra-day high of $0.83 before closing at $0.79. Volume was 2.8x trailing-3-month average.

No comments:

Post a Comment